跳至主要内容
临床试验/NCT05268406
NCT05268406Unknown不适用

Evaluation of C-Scan in Identifying Subjects With Elevated Risk of Polyps in the Colon

Check-Cap Ltd.10 个研究点 分布在 1 个国家目标入组 800 人开始时间: 2020年7月29日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
800
试验地点
10
主要终点
Determine the ability of the C-Scan System to identify elevated risk subjects

研究概览

简要总结

The purpose of the first part of the study (subgroup R&D) is to demonstrate the safety and performance of the C-Scan system and to collect data in order to improve the analysis process. The purpose of the second part of the study (subgroup pre-pivotal) is to determine the ability of the C-Scan System to identify elevated risk subjects

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Screening
盲法
None

入排标准

年龄范围
50 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Male or Female at the age of 50-75 years old
  • •Able to provide a signed informed consent.
  • •Willing and able to comply with the specified study requirements and can be contacted by telephone.
  • •Scheduled for colonoscopy procedure within 60 days of C-Scan ingestion within the research institution's system.*
  • •Maximum body (abdominal) circumference < 125 cm.

排除标准

  • •Subject who is not a suitable candidate for a colonoscopy
  • •Known history of dysphagia or other swallowing disorders.
  • •Third (3rd) and fourth (4th) exclusion criteria are applicable to the pre-pivotal subgroup only:
  • •History of the following:
  • •Previous colon polyps
  • •Personal history of CRC
  • •Family history of CRC or adenomatous polyps diagnosed in a relative before age 60 years
  • •History of inflammatory bowel disease
  • •Having an inherited syndrome (Lynch syndrome, FAB)
  • •GI bleeding within the last 3 months i.e., rectal outlet bleeding, hematochezia or melena
  • •Known motility disorders:
  • •Chronic Constipation: less than three (3) bowel movements/week, without the use of laxatives within the last 3 months.
  • •Delayed gastric emptying.
  • •Ongoing diarrhea defined as passage of loose or watery stools at least three times in a 24-hour.
  • •Known IBD (Crohn's, ulcerative Colitis)
  • •Prior history of gastrointestinal tract surgery.
  • •Prior history of abdominal surgery that might cause bowel strictures leading to capsule retention, as determined by physician discretion.
  • •Any condition believed to have an increased risk for capsule retention, known strictures, any prior episode of bowel obstruction: known bowel adhesion, any 'obstacles' to free passage of the capsule (such as intestinal tumors, radiation enteritis) or incomplete colonoscopies or incomplete colonoscopies as determined by physician discretion.
  • •Significant change in diameter and frequency of stool within the last 3 months
  • •Has an implanted cardiac device or any other implanted active device
  • •Known sensitivity to iodine or hyperthyroidism
  • •Acute kidney failure
  • •Known condition which precludes compliance or is contraindicated with study and/or device instructions.
  • •Has any procedure requiring contrast agent or which may introduce electronic interference (such as magnetic resonance imaging, DEXA scan) or an imaging procedure pre-scheduled within 14 days of C-Scan ingestion
  • •Nuclear imaging procedure during 4 weeks before C-Scan procedure
  • •Known condition of opioid use disorder and/or alcoholism.
  • •Women who are either pregnant or nursing at the time of screening (to be verified by urine or serum pregnancy test for woman of child- bearing potential who are not post-menopausal or undergone surgical sterilization(
  • •Concurrent participation in another clinical trial using any investigational drug or device.

研究组 & 干预措施

Single arm

Experimental

All study participants will undergo the C-Scan System procedure, followed by a standard of care optical colonoscopy

干预措施: C-Scan System (Device)

结局指标

主要结局

Determine the ability of the C-Scan System to identify elevated risk subjects

时间窗: 60 days

Sensitivity for detecting subjects with elevated risk for polyps

次要结局

  • Evaluate the Whole Gut Transit Time(During the C-Scan procedure)
  • Satisfaction with the C-Scan procedure assessed by a questionnaire(Up to 7 days post C-Scan procedure completion)
  • Satisfaction with the C-Scan procedure compared to colonoscopy assessed by a questionnaire(Up to 7 days post colonoscopy)
  • Incidence of device or procedure related adverse events(Up to 7 days post C-Scan procedure completion)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (10)

Loading locations...

相似试验